Phase 1 1 trial
Phase 1
NCT02259855 Jan 2006 → Oct 2008 liver disorder Boehringer Ingelheim
Completed
No outcome recorded
Phase 1/2 2 trials
Phase 1/2
NCT00962715 Apr 2011 → ? chronic lymphocytic leukemia/small lymphocytic lymphoma M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1/2
NCT00120835 Jul 2004 → ? chronic hepatitis C virus infection Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 2 5 trials · 1 met primary
Phase 2
NCT01826981 Apr 2013 → Mar 2015 chronic hepatitis C virus infection Gilead Sciences
Completed
Met primary
Phase 2
NCT01227356 Sep 2004 → Mar 2009 —
Uppsala University
Completed
No outcome recorded
Phase 2
NCT00328549 Oct 2001 → Dec 2002 anemia , hepatitis C virus infection Ortho Biotech Products, L.P.
Completed
No outcome recorded
Phase 2
NCT00323505 Mar 2001 → Dec 2004 plasma cell myeloma Royal Marsden NHS Foundation Trust
Completed
No outcome recorded
Phase 2
NCT00211848 Jun 2000 → Dec 2005 hepatitis C virus infection Icahn School of Medicine at Mount Sinai
Completed
No outcome recorded
Phase 3 3 trials
Phase 3
NCT01858961 May 2013 → Jul 2016 chronic hepatitis C virus infection Boehringer Ingelheim
Withdrawn
No outcome recorded
Phase 3
NCT00147784 Mar 2006 → Jun 2007 hepatitis C virus infection , opiate dependence Sorlandet Hospital HF
Completed
No outcome recorded
Phase 3
NCT00297570 Feb 2006 → ? Philadelphia-positive myelogenous leukemia Sheba Medical Center
Unknown
No outcome recorded
Phase 4 7 trials
Phase 4
NCT03357822 Jan 2018 → Jan 2022 chronic hepatitis B virus infection Tongji Hospital
Unknown
No outcome recorded
Phase 4
NCT01838772 Dec 2013 → Jun 2016 HIV infectious disease , hepatitis C virus infection amfAR, The Foundation for AIDS Research
Completed
No outcome recorded
Phase 4
NCT00167557 Jan 2005 → Mar 2008 hepatitis C virus infection The University of Texas Health Science Center, Houston
Withdrawn
No outcome recorded
Phase 4
NCT00575224 Oct 2004 → Sep 2009 chronic hepatitis C virus infection Pacific Health Foundation
Completed
No outcome recorded
Phase 4
NCT01120795 Feb 2004 → Jan 2006 chronic hepatitis C virus infection Melbourne Health
Completed
No outcome recorded
Phase 4
NCT00194480 Apr 2003 → Dec 2006 hepatitis C virus infection , substance-related disorder National Institute on Drug Abuse (NIDA)
Completed
No outcome recorded
Phase 4
NCT00132210 Sep 2002 → Jun 2010 HIV infectious disease , hepatitis C virus infection University Hospital, Bonn
Completed
No outcome recorded
Comparator or background therapy 19 trials
Phase 1
NCT01525628 Background Apr 2012 → Dec 2013 chronic hepatitis C virus infection Boehringer Ingelheim
Completed
No outcome recorded
Phase 2
NCT04426968 Background Jun 2021 → Nov 2023 chronic hepatitis B virus infection Shanghai HEP Pharmaceutical Co., Ltd.
Completed
No outcome recorded
Phase 2
NCT01852604 Background Mar 2013 → Apr 2015 chronic hepatitis C virus infection Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 2
NCT02726789 Background Oct 2012 → Sep 2016 chronic hepatitis B virus infection Replicor Inc.
Completed
No outcome recorded
Phase 2
NCT01355289 Background Nov 2011 → Feb 2014 thrombocytopenia Eisai Inc.
Completed
Met primary
Phase 2
NCT01314261 Background Mar 2011 → Jan 2012 chronic hepatitis C virus infection AbbVie
Completed
Met primary
Phase 2
NCT01273064 Background Jan → Sep 2011 hepatitis C virus infection Conatus Pharmaceuticals Inc.
Terminated
No outcome recorded
Phase 2
NCT01051921 Background Jan 2010 → Nov 2011 hepatitis C virus infection Conatus Pharmaceuticals Inc.
Completed
No outcome recorded
Phase 2
NCT00943761 Background Oct 2009 → May 2013 chronic hepatitis C virus infection Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 2
NCT00704405 Background Mar 2009 → Mar 2012 chronic hepatitis C virus infection Merck Sharp & Dohme LLC
Completed
Met primary
Phase 2
NCT00704184 Background Jul → Dec 2008 chronic hepatitis C virus infection Merck Sharp & Dohme LLC
Completed
Met primary
Phase 2
NCT00606086 Comparator Dec 2007 → Nov 2012 chronic hepatitis C virus infection GlobeImmune
Completed
Missed primary
Phase 2
NCT00315432 Background Sep 2000 → Nov 2003 HIV infectious disease , anemia , hepatitis C virus infection Ortho Biotech Products, L.P.
Completed
No outcome recorded
Phase 3
NCT01655966 Background May 2012 → Feb 2014 chronic hepatitis C virus infection Cairo University
Unknown
No outcome recorded
Phase 4
NCT00560690 Background Dec 2007 → Sep 2010 hepatitis C virus infection Tehran University of Medical Sciences
Completed
No outcome recorded
Phase 4
NCT00148031 Background Sep 2003 → Mar 2007 alcohol dependence , hepatitis C virus infection , substance abuse State University of New York - Upstate Medical University
Completed
No outcome recorded
— NCT00399672 Comparator Jun 2007 → Aug 2010 hepatitis C virus infection University of British Columbia
Completed
No outcome recorded
— NCT00842205 Comparator Jan 2007 → Jun 2009 chronic hepatitis C virus infection , metabolic dysfunction-associated steatohepatitis Charles University, Czech Republic
Unknown
No outcome recorded
— NCT01779518 Background — hepatitis C virus infection Gilead Sciences
Approved for marketing
No outcome recorded
Show 14 more trials